Veeva AI Announced: A New Era for Life Sciences
In a significant move to transform productivity in the life sciences sector, Veeva Systems, a leading cloud software company, has introduced its latest initiative,
Veeva AI. This groundbreaking initiative aims to integrate advanced artificial intelligence functionalities into existing Veeva applications, enhancing automation and efficiency across various business processes.
Veeva AI is set to revolutionize how life sciences companies operate by providing AI capabilities through its established Vault Platform and applications. The introduction includes AI Agents and AI Shortcuts tailored specifically to meet the needs of the industry. This comprehensive approach covers all major functions within Veeva applications, including clinical, regulatory, safety, quality, medical, and commercial areas.
What Is Veeva AI?
Veeva AI brings innovative features designed for quick and efficient deployment of AI in existing applications. At the heart of this initiative are large language models (LLMs) that support application-specific AI Agents. These agents are capable of understanding the context of tasks performed within Veeva applications, equipped with tailored prompts and security measures that allow secure access to application data, documents, and workflows.
Clients looking to implement Veeva AI will have the flexibility to configure and extend these AI Agents to suit their unique business cases. Accessing AI capabilities can be done seamlessly through a chatbot interface or via AI API calls. Moreover, the AI Shortcuts feature enables end-users to automate routine tasks easily, enhancing their productivity.
According to
Peter Gassner, the CEO of Veeva, “Generative AI represents a new computing paradigm that significantly enhances knowledge workers' productivity.” He elaborates that core applications provide structured data, business rules, and workflows, allowing businesses to operate at speeds and scales expected from computers, while generative AI adds human-like capabilities to navigate ambiguous situations, bringing forth insights and answers.
Flexibility and Security
One remarkable attribute of Veeva AI is its independence from specific LLMs, as it supports a wide range of major LLMs. Customers can choose to utilize Veeva’s proprietary LLM or configure Veeva AI to use their unique LLMs. Regardless of the LLM selected, Veeva AI ensures that customer data remains secure and protected.
Peter Gassner emphasizes the crucial role of Veeva applications in the life sciences industry, stating, “Our customers leverage Veeva applications for essential processes ranging from clinical to commercial domains. Our goal is to boost productivity with AI and ultimately deliver treatments to patients faster.”
The implementation of Veeva AI into the core applications means that life sciences companies of all sizes can simply, safely, and compliantly leverage AI in their operations. The first release of this innovative initiative is anticipated in December 2025, and Veeva plans to promote broad and cautious adoption within the industry by licensing the offering on a Vault basis.
Behind the Scenes of Veeva Systems
Veeva Systems, founded in California and with a branch in Tokyo, Japan, stands as a global leader providing cloud software specifically for the life sciences sector. Serving around 1,400 clients, ranging from the largest pharmaceutical companies to emerging biotechnology firms, Veeva offers a comprehensive suite of services that covers the entire lifecycle of pharmaceutical development and commercialization.
As a pioneer in corporate responsibility, Veeva Systems operates as the first publicly traded benefit corporation, balancing the interests of customers, employees, partners, stakeholders, and the service industry. This commitment solidifies its reputation in an industry with high standards for compliance and operational excellence.
For further updates about Veeva and its endeavors in the industry, visit the official website at
Veeva.com and stay connected on LinkedIn:
Veeva Japan LinkedIn.